Loading…
Revascularization as a means of reducing sudden death
From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA a...
Saved in:
Published in: | European heart journal 1986-05, Vol.7 Suppl A, p.181-186 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 186 |
container_issue | |
container_start_page | 181 |
container_title | European heart journal |
container_volume | 7 Suppl A |
creator | Hugenholtz, P G Serruys, P W Laird-Meeter, K Roelandt, J R |
description | From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76894542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76894542</sourcerecordid><originalsourceid>FETCH-LOGICAL-p206t-f9e97e421c2baec39df01ffeca5f27deae67fa7ada2da1eff719dec938e66a143</originalsourceid><addsrcrecordid>eNotj8tKxDAUQLNQxnH0E4Ss3BXyatIsZfAFA4I4MLtyJ7nRSJvWphH06x2wq7M5HDhnZM24rSutm8MFucz5kzHWaK5XZCWs4pKJNalf8RuyKx1M8RfmOCQKmQLtEVKmQ6AT-uJieqe5eI-JeoT544qcB-gyXi_ckP3D_dv2qdq9PD5v73bVKJieq2DRGlSCO3EEdNL6wHgI6KAOwpxKqE0AAx6EB44hGG49Oisb1Bq4khty-98dp-GrYJ7bPmaHXQcJh5JboxuraiVO4s0ilmOPvh2n2MP00y6f8g8BE080</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76894542</pqid></control><display><type>article</type><title>Revascularization as a means of reducing sudden death</title><source>Oxford University Press Archive</source><creator>Hugenholtz, P G ; Serruys, P W ; Laird-Meeter, K ; Roelandt, J R</creator><creatorcontrib>Hugenholtz, P G ; Serruys, P W ; Laird-Meeter, K ; Roelandt, J R</creatorcontrib><description>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</description><identifier>ISSN: 0195-668X</identifier><identifier>PMID: 2941302</identifier><language>eng</language><publisher>England</publisher><subject>Angina Pectoris - therapy ; Angioplasty, Balloon ; Coronary Disease - drug therapy ; Coronary Disease - surgery ; Coronary Disease - therapy ; Coronary Vessels ; Death, Sudden ; Humans ; Myocardial Infarction - therapy ; Myocardial Revascularization ; Streptokinase - administration & dosage ; Streptokinase - therapeutic use</subject><ispartof>European heart journal, 1986-05, Vol.7 Suppl A, p.181-186</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2941302$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hugenholtz, P G</creatorcontrib><creatorcontrib>Serruys, P W</creatorcontrib><creatorcontrib>Laird-Meeter, K</creatorcontrib><creatorcontrib>Roelandt, J R</creatorcontrib><title>Revascularization as a means of reducing sudden death</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</description><subject>Angina Pectoris - therapy</subject><subject>Angioplasty, Balloon</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - surgery</subject><subject>Coronary Disease - therapy</subject><subject>Coronary Vessels</subject><subject>Death, Sudden</subject><subject>Humans</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocardial Revascularization</subject><subject>Streptokinase - administration & dosage</subject><subject>Streptokinase - therapeutic use</subject><issn>0195-668X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><recordid>eNotj8tKxDAUQLNQxnH0E4Ss3BXyatIsZfAFA4I4MLtyJ7nRSJvWphH06x2wq7M5HDhnZM24rSutm8MFucz5kzHWaK5XZCWs4pKJNalf8RuyKx1M8RfmOCQKmQLtEVKmQ6AT-uJieqe5eI-JeoT544qcB-gyXi_ckP3D_dv2qdq9PD5v73bVKJieq2DRGlSCO3EEdNL6wHgI6KAOwpxKqE0AAx6EB44hGG49Oisb1Bq4khty-98dp-GrYJ7bPmaHXQcJh5JboxuraiVO4s0ilmOPvh2n2MP00y6f8g8BE080</recordid><startdate>19860501</startdate><enddate>19860501</enddate><creator>Hugenholtz, P G</creator><creator>Serruys, P W</creator><creator>Laird-Meeter, K</creator><creator>Roelandt, J R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19860501</creationdate><title>Revascularization as a means of reducing sudden death</title><author>Hugenholtz, P G ; Serruys, P W ; Laird-Meeter, K ; Roelandt, J R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p206t-f9e97e421c2baec39df01ffeca5f27deae67fa7ada2da1eff719dec938e66a143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Angina Pectoris - therapy</topic><topic>Angioplasty, Balloon</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - surgery</topic><topic>Coronary Disease - therapy</topic><topic>Coronary Vessels</topic><topic>Death, Sudden</topic><topic>Humans</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocardial Revascularization</topic><topic>Streptokinase - administration & dosage</topic><topic>Streptokinase - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hugenholtz, P G</creatorcontrib><creatorcontrib>Serruys, P W</creatorcontrib><creatorcontrib>Laird-Meeter, K</creatorcontrib><creatorcontrib>Roelandt, J R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hugenholtz, P G</au><au>Serruys, P W</au><au>Laird-Meeter, K</au><au>Roelandt, J R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Revascularization as a means of reducing sudden death</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>1986-05-01</date><risdate>1986</risdate><volume>7 Suppl A</volume><spage>181</spage><epage>186</epage><pages>181-186</pages><issn>0195-668X</issn><abstract>From this brief overview the arguments have become clear why further studies are needed to verify that the problem of unnecessary sudden cardiac death can best be tackled by a strategy aimed at early and complete revascularization. Whether such a strategy begins with intravenous injection of rt-PA at home or requires subsequent intracoronary manipulation when obstruction persists, whether by thrombolysis with other agents, PTCA or bypass surgery, is in itself a moot point. The main aim should be to offer this strategy as the best chance to reduce the unnecessary sudden death rate which presently accounts for between 25 and 50% of all cardiac deaths. This approach deserves consideration particularly since earlier approaches employing cardioprotective efforts by beta blockade or by anti arrhythmic agents have patently shown that they cannot tackle the problem in a convincing manner.</abstract><cop>England</cop><pmid>2941302</pmid><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-668X |
ispartof | European heart journal, 1986-05, Vol.7 Suppl A, p.181-186 |
issn | 0195-668X |
language | eng |
recordid | cdi_proquest_miscellaneous_76894542 |
source | Oxford University Press Archive |
subjects | Angina Pectoris - therapy Angioplasty, Balloon Coronary Disease - drug therapy Coronary Disease - surgery Coronary Disease - therapy Coronary Vessels Death, Sudden Humans Myocardial Infarction - therapy Myocardial Revascularization Streptokinase - administration & dosage Streptokinase - therapeutic use |
title | Revascularization as a means of reducing sudden death |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T19%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Revascularization%20as%20a%20means%20of%20reducing%20sudden%20death&rft.jtitle=European%20heart%20journal&rft.au=Hugenholtz,%20P%20G&rft.date=1986-05-01&rft.volume=7%20Suppl%20A&rft.spage=181&rft.epage=186&rft.pages=181-186&rft.issn=0195-668X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E76894542%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p206t-f9e97e421c2baec39df01ffeca5f27deae67fa7ada2da1eff719dec938e66a143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76894542&rft_id=info:pmid/2941302&rfr_iscdi=true |